Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy
Background: Integrase inhibitors (INI) induce a rapid decline of HIV-RNA in plasma and CD4+ T-cell recovery in blood. Both characteristics are also associated with immune reconstitution inflammatory syndrome (IRIS). Whether the use of INI-containing combination antiretroviral therapy (cART) increase...
Main Authors: | Ingeborg E.A. Wijting, Ferdinand W.N.M. Wit, Casper Rokx, Eliane M.S. Leyten, Selwyn H. Lowe, Kees Brinkman, Wouter F.W. Bierman, Marjo E.E. van Kasteren, Anneloes M. Postma, Vera C.M. Bloemen, Ghariba Bouchtoubi, Andy I.M. Hoepelman, Marchina E. van der Ende, Peter Reiss, Bart J.A. Rijnders |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-12-01
|
Series: | EClinicalMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537019302093 |
Similar Items
-
Integrase and integration: biochemical activities of HIV-1 integrase
by: Deprez Eric, et al.
Published: (2008-12-01) -
Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
by: Jennifer L Elliott, et al.
Published: (2020-09-01) -
HIV Integrase Inhibitor Pharmacogenetics: An Exploratory Study
by: Murrell, Derek E., et al.
Published: (2019) -
The use of integrase inhibitors in treatment-experienced patients
by: Gatell Jose M
Published: (2009-11-01) -
HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)